Chihiro Namatame

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder

K. Fujihara, T. Misu, M. Aoki, 2021, Heliyon.

Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.

Y. Itoyama, K. Fujihara, H. Lassmann, 2021, Brain : a journal of neurology.

A thyroid storm patient with protracted disturbance of consciousness and reversible lesion in the splenium of corpus callosum

T. Sonoo, Kensuke Nakamura, Kazutaka Fukushima, 2018, Medicine.

Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.

K. Fujihara, T. Misu, H. Kuroda, 2023, Brain : a journal of neurology.

Humanized-Aquaporin-4-Expressing Rat Created by Gene-Editing Technology and Its Use to Clarify the Pathology of Neuromyelitis Optica Spectrum Disorder

T. Misu, Y. Takai, Y. Miyasaka, 2024, International journal of molecular sciences.